ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Roche's first FDA-approved tumour-agnostic medicine worldpharmanews
August 19, 2019Roche announced that the US Food and Drug Administration (FDA) has approved Rozlytrek? (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC).
Pharma Sources Insight January 2025
